Skip to main content

Table 1 Patient demography and oncological outcome

From: Does preoperative percutaneous nephrostomy insertion worsen upper-tract urothelial cancer oncological outcome? A retrospective single center study

  Preop PCN(+) Preop PCN(−)  
n = 25 n = 639
Gender(Male/Female) 11/14 366/273 0.189
Age(years) 70.8 ± 9.1 67.17 ± 10.8 0.098
Follow up duration 37.9 ± 27.8 48.6 ± 31.4 0.119
pT stage    0.353
 pT0 6 181  
 pT1 10 174  
 pT2 5 122  
 pT3 3 154  
 pT4 1 8  
Papillary 18 506 0.378
Tumor location
 RP tumor 4 264 0.011
 U tumor 17 236 0.002
 RP + U tumor 4 138 0.790
High grade 23 578 0.796
LVI 6 97 0.232
CIS 7 226 0.449
Multifocal 9 189 0.491
TN 7 184 0.931
Smoking 5 65 0.116
ESRD 5 132 0.937
Prior bladder Ca 6 147 0.908
Oncological result
 Bladder recurrence 8 201 0.983
 Local recurrence 4 101 0.804
 Distant metastasis 1 96 0.201
 Cancer specific death 1 72 0.254
  1. RP tumor renal pelvis tumor, U tumor ureter tumor, LVI lymphovascular invasion
  2. CIS carcinoma in situ, TN tumor necrosis, ESRD end stage renal disease